ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.290
-0.010 (-0.43%)
Dec 5, 2025, 4:00 PM EST - Market closed
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $2.26 billion as of December 5, 2025. Its market cap has decreased by -39.50% in one year.
Market Cap
2.26B
Enterprise Value
2.86B
1-Year Change
-39.50%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $2.26B, a decrease of -84.78%. That is a compound annual growth rate of -32.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.26B | 20.67% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |